Perrigo (PRGO) Gross Margin (2012 - 2026)
Perrigo's (PRGO) quarterly Gross Margin came in at 30.69% in Q2 2026, down 367.0% year-over-year from 11.49% in Q2 2025, and down 8.62% quarter-over-quarter from 33.58% in Q1 2026.
Analysis
Perrigo (PRGO) Gross Margin (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Gross Margin for 15 consecutive years, with 30.69% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gross Margin fell 367.0% year-over-year to 30.69% in Q2 2026; TTM through Jun 2026 was 33.26%, a 246.0% decrease from a year earlier, with the FY2025 full-year figure at 35.14%, down 14.0% from the prior year.
- Gross Margin was 30.69% for Q2 2026 at Perrigo, down from 33.58% in the prior quarter.
- Over five years, Gross Margin peaked at 37.58% in Q1 2025 and troughed at 30.69% in Q2 2026.
- A 5-year average of 34.52% and a median of 34.13% in 2025 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin sank 504 bps in 2022 and soared 452 bps in 2025, its largest moves.
- Over 5 years, Gross Margin stood at 33.12% in 2022, then increased by 12 bps to 36.93% in 2023, then dropped by 8 bps to 33.9% in 2024, then fell by 4 bps to 32.64% in 2025, then decreased by 6 bps to 30.69% in 2026.
- The last three Gross Margin figures came in at 30.69% (Q2 2026), 33.58% (Q1 2026), and 32.64% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 61.48% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 58.18% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 38.27% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 45.71% |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 30.69% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 77.67% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 42.54% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Honest Company | 604.06 Mn | 498.16 Mn | 40.36 Mn | 48.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 30.69% |
| Mar 28, 2026 | 33.58% |
| Dec 31, 2025 | 32.64% |
| Sep 27, 2025 | 36.14% |
| Jun 28, 2025 | 34.36% |
| Mar 29, 2025 | 37.58% |
| Dec 31, 2024 | 33.90% |
| Sep 28, 2024 | 37.19% |
| Jun 29, 2024 | 37.04% |
| Mar 30, 2024 | 33.06% |
| Dec 31, 2023 | 36.93% |
| Sep 30, 2023 | 36.59% |
| Jul 1, 2023 | 35.87% |
| Apr 1, 2023 | 35.02% |
| Dec 31, 2022 | 33.12% |
| Oct 1, 2022 | 32.98% |
| Jul 2, 2022 | 33.17% |
| Apr 2, 2022 | 31.44% |
| Dec 31, 2021 | 32.80% |
| Oct 2, 2021 | 32.26% |